COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)
COVID-19 hospitalization was low in AML and MDS but carried a high mortality risk. Post-HSCT, the mortality is high, warranting research into understanding the underlying factors.
Authors
- Madhumithaa Jagannathan
- Diviya Bharathi Ravikumar (ORCID: https://orcid.org/0000-0002-9151-5960)
- Shanthi Reddy Sripathi
- Dinesh Kumar Shanmugam
- Barath Prashanth Sivasubramanian (ORCID: https://orcid.org/0000-0002-6018-5647)
- Raghavendra Tirupathi (ORCID: https://orcid.org/0000-0001-5761-5389)
- Shyamaladevi Babu (ORCID: https://orcid.org/0000-0001-7407-5273)
- Priyanshu Jain
- Rutul Dalal
- Bharath Duraisamy Swami Kannan
- Avinash Javvaji
- Suhasini Joshi (ORCID: https://orcid.org/0009-0009-0783-9662)
Institutions
- Shanghai Medical College of Fudan University (CN)
- PSG Institute of Medical Sciences & Research (IN)
- Maharashtra Institute of Medical Science and Research (IN)
- Northeast Georgia Medical Center (US)
- M.S. Ramaiah Medical College (IN)
- St. Joseph Medical Center in Tacoma (US)
- ESI - Post Graduate Institute of Medical Science and Research (IN)
- Maharashtra Institute of Medical Education and Research
- Institute of Medical Sciences (IN)
- Kasturba Medical College, Manipal (IN)
- Penn State Milton S. Hershey Medical Center (US)
- Osmania Medical College (IN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.3389/fonc.2024.1446482
- Citations
- 2
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.57